EP0247345A3 - 1,4-Dihydropyridine-3,5-dicarboxylates incorporant une partie alkylèneaminoalkylène contenant un hétéroatome - Google Patents

1,4-Dihydropyridine-3,5-dicarboxylates incorporant une partie alkylèneaminoalkylène contenant un hétéroatome

Info

Publication number
EP0247345A3
EP0247345A3 EP87105601A EP87105601A EP0247345A3 EP 0247345 A3 EP0247345 A3 EP 0247345A3 EP 87105601 A EP87105601 A EP 87105601A EP 87105601 A EP87105601 A EP 87105601A EP 0247345 A3 EP0247345 A3 EP 0247345A3
Authority
EP
European Patent Office
Prior art keywords
alkyleneaminoalkylene
dihydropyridine
dicarboxylates
incorporating
heteroatom moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP87105601A
Other languages
German (de)
English (en)
Other versions
EP0247345A2 (fr
Inventor
Graham S. Poindexter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co, Bristol Myers Squibb Co filed Critical Bristol Myers Co
Publication of EP0247345A2 publication Critical patent/EP0247345A2/fr
Publication of EP0247345A3 publication Critical patent/EP0247345A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP87105601A 1986-04-16 1987-04-15 1,4-Dihydropyridine-3,5-dicarboxylates incorporant une partie alkylèneaminoalkylène contenant un hétéroatome Ceased EP0247345A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/852,856 US4814455A (en) 1986-04-16 1986-04-16 Dihydro-3,5-dicarboxylates
US852856 1997-05-07

Publications (2)

Publication Number Publication Date
EP0247345A2 EP0247345A2 (fr) 1987-12-02
EP0247345A3 true EP0247345A3 (fr) 1987-12-23

Family

ID=25314403

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87105601A Ceased EP0247345A3 (fr) 1986-04-16 1987-04-15 1,4-Dihydropyridine-3,5-dicarboxylates incorporant une partie alkylèneaminoalkylène contenant un hétéroatome

Country Status (4)

Country Link
US (1) US4814455A (fr)
EP (1) EP0247345A3 (fr)
JP (1) JPS62281860A (fr)
CA (1) CA1320205C (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59632B1 (en) * 1985-08-21 1994-03-09 Glaxo Spa Heterocyclic derivatives
US5602174A (en) * 1986-02-15 1997-02-11 Beecham Wuefling Gmbh & Co. Treatment
GB8603765D0 (en) * 1986-02-15 1986-03-19 Beecham Wuelfung Gmbh & Co Kg Compounds
JPS63112560A (ja) * 1986-10-29 1988-05-17 Green Cross Corp:The ジヒドロピリジン誘導体
DE4131346A1 (de) * 1991-09-20 1993-03-25 Bayer Ag Indolsulfonamid substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
JP4734924B2 (ja) * 2004-01-13 2011-07-27 三菱瓦斯化学株式会社 環状カルバミン酸エステルの製造方法
US10576072B2 (en) * 2016-01-26 2020-03-03 Ataturk Universitesi Bilimsel Arastirma Projeleri Birimi N3,N6-bis(2-(5-methoxy-1H-indole-3-yl)ethyl)-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxamide and use thereof in the field of neurotoxicity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094159A1 (fr) * 1982-05-10 1983-11-16 Takeda Chemical Industries, Ltd. Dérivés de la dihydropyridine, leur préparation et leur application
EP0128010A2 (fr) * 1983-06-02 1984-12-12 Teijin Limited Dérivés de 1,4-dihydropyridines, leur procédé de préparation et utilisation en pharmacie
EP0151006A2 (fr) * 1984-01-25 1985-08-07 Yamanouchi Pharmaceutical Co., Ltd. Dérivés de dihydropyridine, leur procédé de préparation, les compositions pharmaceutiques les contenant, et les procédés de préparation de ces compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
US3883543A (en) * 1969-05-10 1975-05-13 Bayer Ag N-alkyl-1,4-dihydropyridines
CH603575A5 (fr) * 1974-08-19 1978-08-31 Hoffmann La Roche
JPS5762257A (en) * 1980-10-03 1982-04-15 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
WO1983003249A1 (fr) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical Derives de 1,4-dihydropyridine-3,5-dicarboxylate
IL68524A0 (en) * 1982-05-21 1983-07-31 Haessle Ab Novel dihydropyridines
DE3377352D1 (en) * 1982-06-03 1988-08-18 Pierrel Spa Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
JPS60136558A (ja) * 1983-12-24 1985-07-20 Teikoku Hormone Mfg Co Ltd １，４−ジヒドロピリジン誘導体
IL77843A (en) * 1985-02-11 1989-07-31 Syntex Inc Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094159A1 (fr) * 1982-05-10 1983-11-16 Takeda Chemical Industries, Ltd. Dérivés de la dihydropyridine, leur préparation et leur application
EP0128010A2 (fr) * 1983-06-02 1984-12-12 Teijin Limited Dérivés de 1,4-dihydropyridines, leur procédé de préparation et utilisation en pharmacie
EP0151006A2 (fr) * 1984-01-25 1985-08-07 Yamanouchi Pharmaceutical Co., Ltd. Dérivés de dihydropyridine, leur procédé de préparation, les compositions pharmaceutiques les contenant, et les procédés de préparation de ces compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN, vol. 9, no. 293 (C-315)[2016], 20th November 1985; & JP - A - 60 136 558 (TEIKOKU ZOKI SEIYAKU K.K.) 20-07-1985 *

Also Published As

Publication number Publication date
JPH0515704B2 (fr) 1993-03-02
JPS62281860A (ja) 1987-12-07
CA1320205C (fr) 1993-07-13
EP0247345A2 (fr) 1987-12-02
US4814455A (en) 1989-03-21

Similar Documents

Publication Publication Date Title
AU628138B2 (en) Triazine derivative and herbicide containing the same as active ingredient
BR1100621A (pt) Compostos
GR3006319T3 (fr)
AU536055B2 (en) Derivatives of 1,4 dihydropyridine substituted by benzoxadiazole or benzthiadiazole
AU581434B2 (en) New ``-carboline-3-oxadiazolyl derivatives
EP0247345A3 (fr) 1,4-Dihydropyridine-3,5-dicarboxylates incorporant une partie alkylèneaminoalkylène contenant un hétéroatome
CA2026778A1 (fr) Composs de type dioxaphosphorinane et compositions de polyolefines stabilisees par ceux-ci
DE69403541T2 (de) Lacton-Verbindung und Verfahren zu ihrer Herstellung
AU546961B2 (en) 2,3-dihydro-2-oxo-1h-imidazole derivatives
EP0230474A4 (fr) Derives de bis-dioxopiperazine et compositions de medicaments les contenant.
TW223057B (fr)
CA1262906C (fr) 3-(2-furoyl)-5-alcoxycarbonyl-2,6-dimethyl-4- (2-nitrophenyl)-1,4-dihydropyridines, antagonistes pour le calcium
AU2167588A (en) Diphenyl ether herbicides
MY106898A (en) Aromatic compounds, their production processes and their compositions for the control of insect pests
AU546960B2 (en) 1,3-dihydro-2h-imidazol-2-one derivatives
IL78625A0 (en) Furanone derivatives and their preparation
NO922795L (no) Anvendelse av 1,4-dihydropyridiner ved diabetes
JPS57108089A (en) Novel 4-(2,1,3-benzoxadiazole-4-yl)-1,4- dihydro-pyridine derivative
EP0258009A3 (en) 2,6-bis(chloromethyloxycarbonyloxymethyl)pyridine
TH2282EX (th) สารเฟนนิลซัลโฟนิล กวานิดีน ที่มีกลุ่มแทนที่ชนิดใหม่สำหรับปราบวัชพืชและสารรายทาง
ES534272A0 (es) Procedimiento de obtencion de 2, 6-dimetil-4-(3'-nitrofenil)-1, 4-dihidropiridin-3, 5-dicarboxilato de 2-n-propoxietilo

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

17P Request for examination filed

Effective date: 19880616

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORP.)

17Q First examination report despatched

Effective date: 19900813

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19930522

RIN1 Information on inventor provided before grant (corrected)

Inventor name: POINDEXTER, GRAHAM S.